Product Category

Others > >

TeleCervico System(Pd No. : 3085140)

(Updated : 08/10/2017)
TeleCervico System
  • TeleCervico System
  • TeleCervico System
  • TeleCervico System
product information
Model Nm
HS CODE 901890
M.O.Q
Ceritification CE FDA
ISO13485
Keywords telecervico, cervicography, colposcopy, cervix, screening, uterus, cervical cancer
Seller ID ntlasia
Payment Card Master VISA JCB

PRODUCT DETAILS

The TeleCervicography system, TeleCervico®, is a remote cervical cancer screening system. It complements the high false negative rate(approximately 50%) of Pap smear as it can raise sensitivity up to 98.1% when combined with Pap smear and 94% as a sole method. Currently it has been proved to be a very effective and economical screening method that made more than 5 million women use the TeleCervico®.


It's wireless cervical camera. TeleCervico® can also be used as a documentary camera in the operation room because it doesn't have any wires which means it is easy to carry.


Compared to the former screening test which takes maximum a week, TeleCervico® is cost-effective in that it takes less than 24 hours.


-Size: Width x Length x Height (192 x 134 x 235.5mm)


-Benefits

·Prompt Interpretation result(Within Maximum 24hours)

·No Geographic Restriction to Access to care

·No Paper for test request and report

·Reduce Labor and Consumables for delivery, test processing, and etc.

·Screening Method using the principle of Colposcopy

·Effective and Economical Screening

·Easy Follow-up before and after treatment / examination


-Feature

1. A Wireless Cervical Camera

2. Medical S/W Programs

3. Specialized evalutaors for examination.




COMPANY INTRODUCTION


·1996 - Founded the company

·1997 - Participated in the project of research and deveoplment to overcome cancers managed by the Ministry of Health and Welfare

·2003 - Developed Remote Cervical Cancer Screening System(TeleCervico®) and released it to the market

·2006 - Presented the thesis of the excellent clinical effects of TeleCervico® to ASCCP(American Society of Colposcopy & Cervical Pathlogy) in June and to FIGO in Nov.

·2008 - Got U.S FDA approval and Europe CE certification for TeleCervico®

·2008 - Registered a patent application in Korea and applied for an internatioanl patent, "Remote Cervical Cancer Screening System and the Method using TeleCervico®"

·2010 - Be selected as a quality, high-technology & trustworthiness brand by KOTRA

·2017 - Maintaining clinical dianostic service contracts with more than 1,000 hospitals & clinics


-VISION

IDO Co., LTD provides constant services with accumulated experiences in the field of woman cancer. We make efforts in order to get results rapidly and accurately. Through the screening method innovation, we would contribute on improvement of human's quality of life.

As a leading company of health care industry, our mission is to become a company which participates in society growth. Also, we pursuit communication with people and diversity which would be concluded to new thinking infinite challenge, and sharing of love.


-BUSINESS MODEL

Cervical cancer screening ; TeleCervico system, cytology test, HPVtest, STItest etc.




Company Information

company information
Contact Person HYEONSU SHIN
Company NTL Co., Ltd.
Address 201, 12, Songpa-daero 26-gil Songpa-gu, Seoul, Korea
Homepage www.telecervico.com , http://seller.buykorea.org/ntl--1034463
Tel 024017799 Fax 0312763166
Biz. Type Manufacturing and trade Est. Year -
Employees 11~50

Company Profile

Company Profile
About Company The Analogue Cervicography (Screening test of Cervix), which is developed in University of Wisconsin, was first adopted domestically by NTL Co., Ltd. Since then we have made efforts in order to drop the incidence rate of cervical cancer, and thus, it has succeed as the rate shifted from 1st place to 7th place.
NTL, however, instead of staying still with the results, continued researching and developing to realize the availability of cervicography whenever and wherever the Internet is connected. In 2003, the web-based cervicography was developed, and in 2012, the world first wireless cervicography was developed by NTL. Nowadays, the cervicography service is provided to domestic hospitals and clinics, and also those of abroad as well.
As a result, NTL could become the top cervical screening service company with systematic quality control and by integrating all the other cervical cancer screening tests domestically.
Company History -1996 Founded NTL Co., Ltd.
-1997 Participated in the project of research and development to overcome cancers managed by the Ministry of Health and Welfare
-2003 Developed Remote Cervical Cancer Screening System (TeleCervico) and released it to the market
-2004 Released the on-and off-line integrated version of TeleCervico
-2006 Presented the thesis of the excellent clinical effects of TeleCervico to ASCCP in June and to FIGO in Nov
-2008 Got U.S FDA approval and Europe CE certification for TeleCervico
-2012 Invented the world’s only wireless WiFi cervical camera
Participated Telecervico exhibition at Arab Health 2012, Dubai
-2013 Introduced Telecervico to National Ob&Gy Hospital of Vietnam and Vietnam-France OBGY Conference
-2016 Seminar at ASCCP and AACR
-2017 Maintaining clinical diagnostic service contracts with more than 1,000 hospitals & clinics
Cooperated with Korean College of Obstetrics & Gynecology as a main sponsor of Symposiums at 16 regions

Other Products from [ ntlasia ] (4)

View all
Related Business Event List
Korea Service Market 2017 COEX B2 2017-06-15 ~ 2017-06-16

Inquiry

  • - Please leave a detailed inquiry to get an accurate reply from the Korean seller.
Inquiry
To NTL Co., Ltd.
CC  You are able to send one CC-mail ONLY
Message
CUSTOMER
CENTER
top

QUICK MENU
QR
Loading...